Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) is pleased to announce that, the Drug Registration Certificate for in-licensed product Natulan® (Procarbazine Capsules) has been obtained from the China National Medical Products Administration (“NMPA”). Natulan® has been approved for use in combination with other anticancer drugs to treat Hodgkin’s Lymphoma (“HL”).
Thai 
English